Oct
2026
Fiera Milano, Italy
Visit us
stand 14C26, Finished Dosage & Formulation
Zone

Zhejiang Hisun Pharmaceutical Co.,Ltd.

Exhibitor at CPHI Milan 2026
About Us

Hisun Pharmaceutical was established in 1956. The company manufactures over 100 APIs, with a focus on oncology, anti-infectives, cardiovascular health, immunosuppressants, and animal healthcare. Hisun has built a robust technology platform offering CMO/CDMO services in both fermentation and synthetic processes. With world-class fermentation capabilities—from strain development to large-scale production, Hisun leveraged its pharmaceutical expertise in microbial fermentation to support the nutraceuticals, dietary supplements, and cosmetics sectors.


  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    5000+
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Veterinary Company
Primary activities
Animal Health
API Producer
Biopharmaceutical
Contract Manufacturer
Cosmetic Ingredients
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Intermediates Manufacturer
Nutraceuticals
Pharmaceutical Company (generic finished products)
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 14C26, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • Acarbose

    Product Acarbose

    Antidiabetic AgentsJP, USP, EP, ChP, IP
    USDMF, CEP, JDMF, CDE(A)
  • Orlistat

    Product Orlistat

    OTC weight-reducing drug
    USP
    EDMF, CDE(A)
  • Tigecycline

    Product Tigecycline

    Anti-infective APIUSP, EP, YBY
    USDMF, CEP(SUBMITTED), CDE(A)
  • Meropenem

    Product Meropenem

    Anti-infective APIUSP, JP, ChP
    JDMF, CDE(A)
  • Isepamicin Sulfate

    Product Isepamicin Sulfate

    Anti-infective APIChP+YBH
    CDE(A)